April 4, 2017 / 10:15 AM / 4 months ago

BRIEF-Aviragen Therapeutics announces review of strategic alternatives

1 Min Read

April 4 (Reuters) - Aviragen Therapeutics Inc

* Company has retained Stifel, Nicolaus & Company, incorporated to serve as its financial advisor in process

* Aviragen therapeutics announces review of strategic alternatives and provides corporate update

* Does not have a defined timeline for exploration of strategic alternatives

* To explore strategic alternatives that include business combination or merger, in-licensing clinical stage programs, deal or other transaction

* Aviragen is not confirming that process will result in any strategic alternative being announced or consummated Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below